Subclinical hypothyroidism is a common thyroid disorder that often goes unnoticed but can have significant impacts on health. This blog post aims to demystify this condition.
What is Subclinical Hypothyroidism?
Subclinical hypothyroidism is a mild form of thyroid dysfunction characterized by:
Elevated thyroid-stimulating hormone (TSH) levels
Normal free thyroxine (T4) levels
It affects up to 10% of the adult population, with higher prevalence in women and older individuals[1][2].
Causes
The most common cause of subclinical hypothyroidism is Hashimoto’s thyroiditis, an autoimmune condition. Other causes include:
Iodine deficiency
Previous thyroid surgery or radiation
Certain medications (e.g., lithium, amiodarone)
Pituitary dysfunction (rarely)[1][3]
Diagnosis
Diagnosis is based on thyroid function tests (TFTs):
TSH: Elevated (typically 4.5-10 mIU/L)
Free T4: Within normal range
It’s important to note that TSH levels can fluctuate, so repeated testing is often necessary for accurate diagnosis[4].
Symptoms
Many patients with subclinical hypothyroidism are asymptomatic. However, some may experience mild symptoms such as:
Fatigue
Weight gain
Dry skin
Cold intolerance
Mild cognitive impairment[2][5]
Treatment
The decision to treat subclinical hypothyroidism is often individualized. The American Association of Clinical Endocrinologists (AACE) recommends considering treatment for:
TSH levels >10 mIU/L
TSH levels between 4.5-10 mIU/L with symptoms or risk factors (e.g., positive thyroid antibodies, cardiovascular risk factors)[6]
Thyroid Function Tests Explained
TSH: Produced by the pituitary gland, it stimulates thyroid hormone production. Elevated levels indicate potential thyroid underactivity.
Free T4: The main hormone produced by the thyroid gland. Normal levels with high TSH characterize subclinical hypothyroidism.
Free T3: The active form of thyroid hormone. It’s not typically used for diagnosing subclinical hypothyroidism but may be considered in some cases.
Treating Within the Normal Range
The concept of treating within the traditional normal range is based on the understanding that individuals have unique “set points” for optimal thyroid function. The AACE suggests a narrower TSH range of 0.5-2.5 mIU/L as potentially more appropriate for many individuals[6].
Thyroid Replacement Options
Levothyroxine (T4): The most commonly prescribed option.
Liothyronine (T3): Sometimes used in combination with T4.
Natural desiccated thyroid (e.g., Armour Thyroid, Nature-Throid): Contains both T4 and T3.
The choice depends on individual patient factors and response to treatment[7].
Health Benefits of Treatment
Treating subclinical hypothyroidism may lead to improvements in:
Lean Body Mass: Proper thyroid function supports muscle health[9].
Mentation: Some studies suggest improvements in cognitive function[10].
Lipid Profile: Treatment may lead to reduced LDL cholesterol levels[11].
Energy Levels: Many patients report increased energy and reduced fatigue[5].
Liver Fat: Thyroid hormones play a role in hepatic lipid metabolism[12].
Cardiovascular Health: Treatment may reduce the risk of heart disease in some patients[13].
Conclusion
Subclinical hypothyroidism is a complex condition that requires careful consideration of individual patient factors. While not all patients require treatment, addressing this condition can lead to significant health benefits for many. As always, decisions about diagnosis and treatment should be made in consultation with a healthcare provider.
Remember, thyroid health is crucial for overall well-being. If you suspect thyroid issues, don’t hesitate to discuss your concerns with your doctor.
Sources [1] Subclinical Hypothyroidism | Endocrinology – JAMA Network https://jamanetwork.com/journals/jama/fullarticle/2737684 [2] Subclinical Hypothyroidism: A Review – PubMed https://pubmed.ncbi.nlm.nih.gov/31287527/ [3] Clinical practice guidelines for hypothyroidism in adults – PubMed https://pubmed.ncbi.nlm.nih.gov/23246686/ [4] [PDF] Interpreting Thyroid Function Tests https://pro.aace.com/sites/default/files/2020-12/AACE%20TRC%20Interpretation%20of%20TFTs%20Part%203-FINAL.pdf [5] Direct effects of thyroid hormones on hepatic lipid metabolism – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC6013028/ [6] Thyroid Hormone Therapy – American Cancer Society https://www.cancer.org/cancer/types/thyroid-cancer/treating/thyroid-hormone-therapy.html [7] Subclinical Hypothyroidism: An Update for Primary Care Physicians https://pmc.ncbi.nlm.nih.gov/articles/PMC2664572/ [8] Subclinical Hypothyroidism: A Review | Endocrinology | JAMA https://jamanetwork.com/journals/jama/article-abstract/2737687 [9] Thyroid Hormone Regulation of Metabolism – PMC – PubMed Central https://pmc.ncbi.nlm.nih.gov/articles/PMC4044302/ [10] Subclinical Hypothyroidism – StatPearls – NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK536970/ [11] Thyroid Hormone Regulation of Metabolism https://journals.physiology.org/doi/pdf/10.1152/physrev.00030.2013 [12] Subclinical Hypothyroidism: Deciding When to Treat – AAFP https://www.aafp.org/pubs/afp/issues/1998/0215/p776.html [13] Subclinical hypothyroidism: Causes, diagnosis, and treatment https://www.medicalnewstoday.com/articles/subclinical-hypothyroidism [14] Subclinical hypothyroidism, outcomes and management guidelines https://www.tandfonline.com/doi/full/10.1080/03007995.2023.2165811 [15] Hypothyroidism (underactive thyroid) – Diagnosis and treatment https://www.mayoclinic.org/diseases-conditions/hypothyroidism/diagnosis-treatment/drc-20350289 [16] Subclinical Hypothyroidism: Prevalence, Health Impact, and … https://e-enm.org/journal/view.php?doi=10.3803%2FEnM.2021.1066 [17] Subclinical Hypothyroidism: What It Is, Symptoms & Treatment https://my.clevelandclinic.org/health/diseases/23544-subclinical-hypothyroidism [18] Subclinical thyroid disease https://www.btf-thyroid.org/subclinical-thyroid-disease [19] Subclinical Hypothyroidism: Treatment, Symptoms, Diet, and More https://www.healthline.com/health/subclinical-hypothyroidism [20] Subclinical hypothyroidism: When to treat https://www.ccjm.org/content/86/2/101 [21] Normal TSH Reference Range: What Has Changed in the Last … https://academic.oup.com/jcem/article/98/9/3584/2833082?login=false [22] Thyroid Guidelines and Algorithms https://pro.aace.com/clinical-guidance/thyroid [23] Clinical Practice Guidelines for Hypothyroidism in Adults https://www.endocrinepractice.org/article/S1530-891X(20)43030-7/fulltext [24] [PDF] Hypothyroidism – | American Association of Clinical Endocrinology https://pro.aace.com/sites/default/files/2021-01/AACE%20Hypothyroidism%20-Part%201-FINAL.pdf [25] Thyroid Hormone Treatment https://www.thyroid.org/thyroid-hormone-treatment/ [26] Effects of Thyroid Hormones on Lipid Metabolism Pathologies in … https://www.mdpi.com/2227-9059/10/6/1232 [27] Thyroid Hormone Replacement Therapy https://www.chop.edu/treatments/thyroid-hormone-replacement-therapy [28] [PDF] The Effects of a Very-Low-Calorie-Diet on Resting Energy … – CORE https://core.ac.uk/download/pdf/77526563.pdf [29] Optimal Thyroid Hormone Replacement – PMC – PubMed Central https://pmc.ncbi.nlm.nih.gov/articles/PMC8905334/ [30] [PDF] Safe Weight Loss and Maintenance Practices in Sport and Exercise https://www.nata.org/sites/default/files/safe_weight_loss_and_maintenance_practices_in_sport_and_exercise.pdf [31] Treatment With Thyroid Hormone – Oxford Academic https://academic.oup.com/edrv/article-abstract/35/3/433/2354656?redirectedFrom=fulltext [32] [PDF] PROTEIN AND AMINO ACID REQUIREMENTS IN HUMAN … https://iris.who.int/bitstream/handle/10665/43411/WHO_TRS_935_eng.pdf [33] Thyroid Hormone Therapy for Thyroid Cancer – Penn Medicine https://www.pennmedicine.org/cancer/types-of-cancer/thyroid-cancer/thyroid-cancer-treatment/thyroid-hormone-therapy-for-thyroid-cancer [34] Managing Abnormal Blood Lipids – AHA Journals https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.105.169180 [35] Benefits of Thyroid Hormone Replacement Therapy – BodyLogicMD https://www.bodylogicmd.com/for-women/thyroid-health/ [36] [PDF] ATA/AACE Guidelines CLINICAL PRACTICE … – Givewell https://files.givewell.org/files/DWDA%202009/Interventions/Iodine/Garber%20et%20al%202012.pdf [37] Subclinical Thyroid Dysfunction: A Joint Statement on Management … https://academic.oup.com/jcem/article/90/1/581/2835677 [38] A Clinical Debate: Subclinical Hypothyroidism – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC8453656/ [39] Thyroid Hormone Replacement Therapy – Johns Hopkins Medicine https://www.hopkinsmedicine.org/health/treatment-tests-and-therapies/thyroid-hormone-replacement-therapy
The Heart Outcomes Prevention Evaluation (HOPE) study, published in 2000, revolutionized our understanding of cardiovascular disease prevention and treatment. This landmark trial investigated the effects of ramipril, an angiotensin-converting enzyme (ACE) inhibitor, on cardiovascular outcomes in high-risk patients. The results were nothing short of groundbreaking, leading to a fundamental shift in how we approach cardiovascular risk reduction.
Study Design and Results
The HOPE study enrolled 9,297 high-risk patients aged 55 or older with evidence of vascular disease or diabetes plus one other cardiovascular risk factor[1]. Participants were randomized to receive either ramipril (10 mg daily) or placebo for a mean of five years. The primary outcome was a composite of myocardial infarction, stroke, or death from cardiovascular causes.
The results were striking:
The primary outcome occurred in 14% of patients in the ramipril group compared to 17.8% in the placebo group, representing a 22% relative risk reduction[1].
Ramipril reduced the rates of:
Death from cardiovascular causes by 26%
Myocardial infarction by 20%
Stroke by 32%
All-cause mortality by 16%
Revascularization procedures by 15%
Cardiac arrest by 38%
Heart failure by 23%
Complications related to diabetes by 16%[3]
These benefits were consistent across various subgroups, including patients with and without diabetes, hypertension, or previous cardiovascular events[1].
Implications and Paradigm Shift
The HOPE study’s findings had far-reaching implications for cardiovascular medicine:
Beyond Blood Pressure Control: While ramipril did lower blood pressure slightly (by 3-4 mmHg systolic and 1-2 mmHg diastolic), this modest reduction couldn’t fully explain the substantial cardiovascular benefits observed[1]. This suggested that ACE inhibitors like ramipril had protective effects beyond mere blood pressure lowering.
Expanded Indications: Prior to HOPE, ACE inhibitors were primarily used for treating hypertension and heart failure. The study’s results supported their use in a much broader population of high-risk patients, even those with normal blood pressure and no heart failure[6].
Primary Prevention: HOPE demonstrated that ramipril could prevent cardiovascular events in patients who had not yet experienced them, expanding the role of ACE inhibitors from treatment to prevention[1].
Pleiotropic Effects: The study highlighted the concept of “pleiotropic effects” – multiple beneficial actions beyond the primary intended effect. For ramipril and other ACE inhibitors, these may include:
Improved endothelial function
Reduced inflammation
Decreased oxidative stress
Plaque stabilization
Enhanced fibrinolysis[1][4]
Diabetes Prevention: Surprisingly, ramipril was associated with a 34% reduction in new-onset diabetes[1]. This unexpected finding opened new avenues for research into the metabolic effects of ACE inhibitors.
Extrapolation to Similar Medications
While the HOPE study specifically examined ramipril, its findings have been largely extrapolated to other ACE inhibitors and, to some extent, angiotensin receptor blockers (ARBs). Subsequent studies with other ACE inhibitors and ARBs have shown similar cardiovascular benefits, supporting a class effect[20][33].
However, it’s important to note that not all studies have shown identical results. For example, the ALLHAT trial found no significant difference in cardiovascular outcomes between the ACE inhibitor lisinopril and other antihypertensive medications[19]. This underscores the complexity of cardiovascular pharmacology and the need for individualized treatment approaches.
The Case for Open-Mindedness in Medication Use
The HOPE study’s results make a compelling case for the judicious use of medications like ramipril in appropriate patients. The benefits observed went far beyond blood pressure control, encompassing reductions in:
Myocardial infarction
Stroke
Cardiovascular death
All-cause mortality
Heart failure
Revascularization procedures
Diabetic complications[3]
For high-risk patients, the potential benefits of ACE inhibitor therapy may far outweigh the risks. Common side effects like cough are generally manageable, and serious adverse events are rare[21].
Conclusion
The HOPE study marked a turning point in cardiovascular medicine, expanding our understanding of ACE inhibitors’ benefits beyond blood pressure control. It highlighted the importance of considering a medication’s pleiotropic effects and treating the patient’s overall cardiovascular risk, not just individual risk factors.
For patients and healthcare providers alike, the study’s results underscore the value of evidence-based medicine and the potential for well-studied medications to offer substantial health benefits. While every treatment decision should be individualized, the HOPE study provides a strong rationale for considering ACE inhibitor therapy in a wide range of high-risk patients.
As we continue to unravel the complex interplay between various physiological systems in cardiovascular health, the lessons from HOPE remain relevant: sometimes, a medication’s most important benefits may extend far beyond its primary indication.
Sources [1] The HOPE Study (Heart Outcomes Prevention Evaluation) – PubMed https://pubmed.ncbi.nlm.nih.gov/11967789/ [2] Morbidity and mortality reduction with ramipril: The latest results of … https://academic.oup.com/ajh/article/13/S2/326A/190104 [3] Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on … https://pubmed.ncbi.nlm.nih.gov/10639539/ [4] [PDF] Pleiotropic benefits and utility of angiotensin converting enzyme … https://www.msjonline.org/index.php/ijrms/article/download/9816/6672/38557 [5] Ramipril – StatPearls – NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK537119/ [6] [PDF] The Hope Study – Cleveland Clinic Journal of Medicine https://www.ccjm.org/content/ccjom/67/4/287.full.pdf [7] Long-term survival benefit of ramipril in patients with acute … https://heart.bmj.com/content/107/5/389 [8] Pleiotropic benefits and utility of angiotensin converting enzyme … https://www.msjonline.org/index.php/ijrms/article/view/9816 [9] The Heart Outcomes Prevention Evaluation Study – HOPE – Ramipril https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2014/09/22/23/12/HOPE–Ramipril [10] Effect of Ramipril on Walking Times and Quality of Life Among … https://jamanetwork.com/journals/jama/fullarticle/1568251 [11] Effects of ramipril on cardiovascular and microvascular outcomes in … https://pubmed.ncbi.nlm.nih.gov/10675071/ [12] Effect of long-term therapy with ramipril in high-risk women https://www.sciencedirect.com/science/article/pii/S0735109702020351 [13] Effects of ramipril on cardiovascular and microvascular outcomes in … https://www.thelancet.com/journals/lancet/article/PIIS0140-6736%2899%2912323-7/abstract [14] Comparative Effects of Ramipril on Ambulatory and Office Blood … https://www.ahajournals.org/doi/10.1161/hy1101.099502 [15] Long-Term Effects of Ramipril on Cardiovascular Events and on … https://www.ahajournals.org/doi/10.1161/circulationaha.105.548461 [16] Prevention of Heart Failure in Patients in the Heart Outcomes … https://www.ahajournals.org/doi/10.1161/01.cir.0000054165.93055.42 [17] Effects of ramipril on cardiovascular and microvascular outcomes in … https://www.sciencedirect.com/science/article/abs/pii/S0140673699123237 [18] Common questions about ramipril – NHS https://www.nhs.uk/medicines/ramipril/common-questions-about-ramipril/ [19] Mortality and Morbidity Among Individuals With Hypertension … https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2812523 [20] Are There Pleiotropic Effects of Antihypertensive Medications or Is It … https://pmc.ncbi.nlm.nih.gov/articles/PMC8673248/ [21] About ramipril – NHS https://www.nhs.uk/medicines/ramipril/about-ramipril/ [22] Ramipril – an overview | ScienceDirect Topics https://www.sciencedirect.com/topics/medicine-and-dentistry/ramipril [23] Pleiotropic effects of calcium channel blockers – Nature https://www.nature.com/articles/s41440-018-0014-8 [24] beyond blood pressure or beyond the brachial artery? – PubMed https://pubmed.ncbi.nlm.nih.gov/15716696/ [25] Comparative Effects of Low and High Doses of the Angiotensin … https://www.ahajournals.org/doi/10.1161/01.cir.100.23.2312 [26] [PDF] Pleiotropic Effects of Ramipril https://www.circulation.or.kr/workshop/2005spring/file/0414/1.Ramipril-4-14-%EA%B0%95%EC%9D%98.pdf [27] Pleiotropic Effects of Angiotensin‐Converting Enzyme Inhibitors and … https://agsjournals.onlinelibrary.wiley.com/doi/full/10.1111/j.1532-5415.2005.53571.x [28] Beyond blood pressure or beyond the brachial artery? – Lippincott https://journals.lww.com/00004872-200503000-00014 [29] Statins and Blockers of the Renin-Angiotensin System – AHA Journals https://www.ahajournals.org/doi/pdf/10.1161/01.HYP.34.4.987 [30] Ramipril (oral route) – Mayo Clinic https://www.mayoclinic.org/drugs-supplements/ramipril-oral-route/description/drg-20069179 [31] Long-term survival benefit of ramipril in patients with acute … https://heart.bmj.com/content/107/5/389 [32] Effect of ramipril on morbidity and mode of death among … – PubMed https://pubmed.ncbi.nlm.nih.gov/9049514/ [33] The Pleiotropic Effects of Angiotensin Receptor Blockers – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC8109722/
Magnesium is a vital mineral involved in over 300 biochemical reactions in the human body. While it’s available in many foods, some individuals may benefit from supplementation. This guide explores various magnesium supplements, their specific uses, and the conditions they may benefit. Bioavailability is the proportion of a drug which enters the circulation when introduced into the body and so is able to have an active effect.
Types of Magnesium Supplements and Their Uses
1. Magnesium Glycinate
Best for: Sleep, anxiety, and overall supplementation
Evidence: Studies suggest magnesium glycinate may improve sleep quality and reduce anxiety symptoms[14][15].
Bioavailability: High, with minimal gastrointestinal side effects
2. Magnesium Citrate
Best for: Constipation, general supplementation
Evidence: Effective as a gentle laxative and for increasing magnesium levels[1][12].
Bioavailability: High, but may cause loose stools in higher doses
3. Magnesium L-Threonate
Best for: Cognitive function, brain health
Evidence: Research indicates potential benefits for learning, memory, and cognitive decline[1][15].
Bioavailability: High, with the ability to cross the blood-brain barrier
4. Magnesium Taurate
Best for: Cardiovascular health, anxiety
Evidence: May help lower blood pressure and reduce anxiety symptoms[14][28].
Bioavailability: Good, with potential calming effects
5. Magnesium Malate
Best for: Muscle pain, fibromyalgia, energy production
Evidence: Some studies suggest benefits for chronic pain conditions[1][20].
Bioavailability: Good, may support cellular energy production
6. Magnesium Oxide
Best for: Constipation, heartburn
Evidence: Effective as a laxative and antacid, but poorly absorbed for increasing magnesium levels[1][3].
Bioavailability: Low, primarily used for its laxative effect
7. Magnesium Chloride
Best for: Topical application, general supplementation
Evidence: May be beneficial for muscle soreness when applied topically[20].
Bioavailability: Good, especially for topical use
Conditions Benefiting from Magnesium Supplementation
Cardiovascular Health
Magnesium may help lower blood pressure and reduce the risk of heart disease[2][13].
A meta-analysis found that higher magnesium intake was associated with a 30% lower risk of cardiovascular disease[1].
Type 2 Diabetes
Magnesium supplementation may improve insulin sensitivity and blood sugar control[13].
One review reported that magnesium supplements improved blood sugar levels in people at risk for type 2 diabetes[13].
Migraines
Some studies suggest magnesium supplementation may help prevent and ease migraine headaches[2][30].
The American Academy of Neurology states that magnesium therapy is “probably effective” for migraine prevention[30].
Bone Health
Magnesium plays a crucial role in bone formation and maintenance[2][13].
Higher magnesium intake is associated with increased bone mineral density[13].
Sleep Quality
Magnesium may help improve sleep quality and duration[13][24].
One study found that magnesium supplementation reduced the time it took to fall asleep by an average of 17 minutes[13].
Anxiety and Depression
Some research suggests magnesium may help alleviate symptoms of anxiety and depression[14][28].
Magnesium plays a role in regulating neurotransmitters that affect mood and stress response[2].
Muscle Cramps and Exercise Performance
Magnesium may help reduce muscle cramps, particularly in pregnant women[2][20].
Some athletes use magnesium to potentially enhance exercise performance and recovery[2].
Constipation
Magnesium citrate and oxide are commonly used as gentle laxatives[1][3].
Asthma
Some studies suggest magnesium supplementation may improve lung function in people with asthma[29].
Intravenous magnesium is sometimes used in emergency treatment of severe asthma attacks[30].
Pre-eclampsia and Eclampsia
Magnesium sulfate is a standard treatment for preventing and treating seizures in severe pre-eclampsia and eclampsia[30].
Dosage and Safety Considerations
The recommended dietary allowance (RDA) for magnesium varies by age and sex, ranging from 310-420 mg per day for adults[26]. However, therapeutic doses may be higher for specific conditions. It’s crucial to consult with a healthcare provider before starting any supplementation regimen.
While magnesium supplements are generally safe, excessive intake can cause side effects such as diarrhea, nausea, and abdominal cramping[27]. Very high doses (around 5,000 mg per day) can be dangerous[27].
Conclusion
Magnesium supplementation offers potential benefits for a wide range of health conditions. The choice of magnesium form should be based on the specific health concern and individual needs. As with any supplement, it’s essential to consult with a healthcare provider to determine the most appropriate form and dosage for your particular situation.
Remember, while supplements can be beneficial, they should not replace a balanced diet rich in magnesium-containing foods such as leafy greens, nuts, seeds, and whole grains. Always prioritize a healthy lifestyle alongside any supplementation strategy.
Sources [1] The Best Types of Magnesium for Health – BodyBio https://bodybio.com/blogs/blog/types-of-magnesium [2] 9 key health benefits of magnesium https://www.bswhealth.com/blog/9-key-health-benefits-of-magnesium [3] Therapeutic Uses of Magnesium – AAFP https://www.aafp.org/pubs/afp/issues/2009/0715/p157.html [4] The Surprising Health Benefits of Magnesium | University Hospitals https://www.uhhospitals.org/blog/articles/2022/09/the-surprising-health-benefits-of-magnesium [5] Best Forms of Magnesium for Anxiety and Depression https://chandramd.com/magnesium-supplements-anxiety/ [6] Types of Magnesium and Their Benefits – Healthline https://www.healthline.com/nutrition/magnesium-types [7] 7 Types of Magnesium: Benefits & Dosage | Nature Made® https://www.naturemade.com/blogs/health-articles/7-types-of-magnesium-their-benefits [8] 7 Conditions Magnesium Can Help With – Health https://www.health.com/conditions-magnesium-can-help-with-8739672 [9] Magnesium Information | Mount Sinai – New York https://www.mountsinai.org/health-library/supplement/magnesium [10] What’s The Best Magnesium Supplement? – Dr. Jolene Brighten https://drbrighten.com/best-magnesium-supplement/ [11] The Surprising Health Benefits of Magnesium | University Hospitals https://www.uhhospitals.org/blog/articles/2022/09/the-surprising-health-benefits-of-magnesium [12] Types of Magnesium and Their Benefits – Healthline https://www.healthline.com/nutrition/magnesium-types [13] What Are the Health Benefits of Magnesium? – Healthline https://www.healthline.com/nutrition/magnesium-benefits [14] A Guide to Magnesium — Team Red, White & Blue https://teamrwb.org/nutrition/guide-to-magnesium [15] What Are the Benefits of Magnesium? – Mount Sinai Today https://health.mountsinai.org/blog/what-are-the-benefits-of-magnesium/ [16] 10 Types of Magnesium: Differences, Benefits, and Uses – Health https://www.health.com/types-of-magnesium-7853312 [17] Magnesium Supplements: Benefits, Deficiency, Dosage … – WebMD https://www.webmd.com/diet/supplement-guide-magnesium [18] Types of Magnesium: What They Are and How to Choose https://www.verywellhealth.com/types-of-magnesium-what-they-are-and-how-to-choose-8748803 [19] Are Magnesium Supplements Good for You? | News & Stories https://www.dartmouth-hitchcock.org/stories/article/are-magnesium-supplements-good-you [20] What Is the Best Magnesium Supplement for Sore Muscles? – BuzzRx https://www.buzzrx.com/blog/what-is-the-best-magnesium-supplement-for-sore-muscles [21] Types of Magnesium: Benefits, side effects, and differences https://www.medicalnewstoday.com/articles/types-of-magnesium [22] Dietitians Pick: 7 Best Magnesium Supplements for 2025 – Healthline https://www.healthline.com/nutrition/best-magnesium-supplement [23] Magnesium – The Nutrition Source https://nutritionsource.hsph.harvard.edu/magnesium/ [24] Using Magnesium for Better Sleep – Sleep Foundation https://www.sleepfoundation.org/magnesium [25] Therapeutic Uses of Magnesium – AAFP https://www.aafp.org/pubs/afp/issues/2009/0715/p157.html [26] Best magnesium supplement 2024: Boost energy and aid restful sleep https://www.livescience.com/best-magnesium-supplement [27] Can Magnesium Supplements Improve Health? – School of Medicine https://medicine.tufts.edu/news-events/news/can-magnesium-supplements-improve-health [28] Which Magnesium is Best for Sleep and Anxiety? And How It Might … https://www.forhers.com/blog/which-magnesium-is-best-for-sleep-and-anxiety [29] Beneficial Effects of Magnesium Supplementation – Sage Journals https://journals.sagepub.com/doi/10.1177/2156587211401746 [30] Magnesium – StatPearls – NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK519036/ [31] Magnesium – Consumer – NIH Office of Dietary Supplements https://ods.od.nih.gov/factsheets/Magnesium-Consumer/
Incretin mimetics, particularly GLP-1 receptor agonists, have revolutionized the treatment of type 2 diabetes (T2D) and obesity. These drugs mimic the effects of natural incretin hormones to regulate blood sugar and promote weight loss. With the success of agents like semaglutide and tirzepatide, pharmaceutical innovation is now focused on developing next-generation incretin mimetics with enhanced efficacy, novel mechanisms, and broader applications. Below, we discuss four promising agents currently in development, their mechanisms of action, unique features, and potential clinical impact.
1. Retatrutide (Eli Lilly)
Mechanism of Action: Retatrutide is a tri-agonist targeting GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This multi-receptor activation aims to amplify metabolic benefits beyond those achieved by dual agonists like tirzepatide[1][2].
Unique Features:
Enhanced Weight Loss: Early-phase trials demonstrated up to 24% body weight reduction over 48 weeks—comparable to bariatric surgery outcomes[1][2].
Broader Metabolic Effects: The inclusion of glucagon receptor activity may enhance energy expenditure and lipid metabolism while preserving lean body mass[1].
Unmet Needs Addressed:
Improved glycemic control and significant weight loss in patients with severe obesity or T2D resistant to current therapies.
Potential Applications:
Beyond T2D and obesity, retatrutide is being investigated for non-alcoholic steatohepatitis (NASH), a liver disease closely linked to metabolic syndrome[1].
Development Stage: Phase 3 trials are ongoing, with FDA approval anticipated by late 2026[1][2].
2. Danuglipron (Pfizer)
Mechanism of Action: Danuglipron is an oral GLP-1 receptor agonist designed to overcome the limitations of injectable formulations[1].
Unique Features:
Oral Administration: Provides a convenient alternative for patients who prefer not to use injections.
Comparable Efficacy: Early data suggest similar weight loss and HbA1c reduction as injectable GLP-1 agonists[1].
Unmet Needs Addressed:
Expands access to incretin therapy for patients hesitant about injectables.
Potential Applications:
Primarily targets diabetes and obesity but could be extended to cardiovascular risk reduction given the class’s proven benefits in this area.
Development Stage: Phase 3 trials are nearing completion, with FDA approval expected in early 2025[1].
3. Efinopegdutide (Hanmi Pharmaceuticals)
Mechanism of Action: Efinopegdutide is a dual GLP-1/glucagon receptor agonist designed for weekly administration. It leverages glucagon receptor activation for enhanced fat oxidation and energy expenditure[1][2].
Unique Features:
Liver-Focused Benefits: Demonstrates potential in treating NASH by reducing liver fat content.
Longer Duration of Action: Weekly dosing improves patient adherence compared to daily regimens[1].
Unmet Needs Addressed:
Addresses both T2D and obesity while targeting liver-specific metabolic dysfunctions like NASH.
Potential Applications:
Could become a cornerstone therapy for metabolic syndrome-related conditions.
Development Stage: Currently in Phase 2 trials; FDA approval might occur around 2027 if results remain favorable[1].
4. Pemvidutide (Altimmune)
Mechanism of Action: Pemvidutide is another dual GLP-1/glucagon receptor agonist but is distinguished by its high potency in reducing body weight and liver fat[1][2].
Unique Features:
Rapid Weight Loss: Phase 2 data showed up to 14% weight loss within just 24 weeks.
Liver Health Benefits: Significant reductions in liver fat make it a strong candidate for NASH treatment[1][2].
Unmet Needs Addressed:
Rapid onset of action for weight loss and liver fat reduction.
Potential Applications:
Likely to be used in both metabolic disease management and liver-specific conditions like NASH.
Development Stage: Phase 3 trials are planned for late 2025; FDA approval could follow by 2028[1].
Comparison & Future Outlook
Drug Name
Mechanism
Unique Feature
Expected FDA Approval
Retatrutide
GLP-1/GIP/Glucagon Triagonist
Unprecedented weight loss
Late 2026
Danuglipron
Oral GLP-1 Agonist
Convenient oral dosing
Early 2025
Efinopegdutide
GLP-1/Glucagon Dual Agonist
Liver-focused benefits
Around 2027
Pemvidutide
GLP-1/Glucagon Dual Agonist
Rapid weight/liver fat loss
By 2028
Danuglipron is likely to be the first approved due to its advanced development stage. Retatrutide may follow shortly after due to its transformative efficacy.
Conclusion
The next wave of incretin mimetics promises groundbreaking advances in treating metabolic diseases. These agents not only enhance current standards for diabetes and obesity but also address unmet needs in conditions like NASH. As these drugs progress through clinical trials, they hold the potential to redefine therapeutic strategies across multiple disciplines.
Sources [1] GLP-1s & Beyond: Understanding Incretin Mimetic Opportunities https://bluematterconsulting.com/glp-1s-and-beyond-incretin-mimetic-market-opportunities/ [2] How should we think about the unprecedented weight loss efficacy … https://pmc.ncbi.nlm.nih.gov/articles/PMC10541183/ [3] [PDF] Therapeutic Class Overview Incretin Mimetics – Nevada Medicaid https://www.medicaid.nv.gov/Downloads/provider/Incretin%20Mimetics.pdf [4] concept.txt – Hugging Face https://huggingface.co/Xikun/greaselm-csqa/resolve/1d90a41f975f4db9e56075201850df49a1be1895/concept.txt?download=true [5] How should we think about the unprecedented weight loss … – JCI https://www.jci.org/articles/view/174597 [6] Incretin Mimetics (GLP-1 Agonists) – Diabetes UK https://www.diabetes.co.uk/diabetes-medication/incretin-mimetics.html [7] Fenugreek: Biology and Applications 9811611963, 9789811611964 https://dokumen.pub/fenugreek-biology-and-applications-9811611963-9789811611964.html [8] January 2025 Newsletter | EGRP/DCCPS/NCI/NIH https://epi.grants.cancer.gov/news/2025/january-newsletter.html [9] Incretin mimetics: a novel therapeutic option for patients with type 2 … https://pmc.ncbi.nlm.nih.gov/articles/PMC3047973/ [10] Incretin-Based Therapies: Viewpoints on the way to consensus https://diabetesjournals.org/care/article/32/suppl_2/S223/27074/Incretin-Based-TherapiesViewpoints-on-the-way-to [11] Mechanisms of action and therapeutic applications of GLP-1 and … https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2024.1431292/full
Incretin mimetics, a class of medications initially developed for type 2 diabetes management, have emerged as a groundbreaking therapeutic option with far-reaching effects beyond glycemic control. As our understanding of these drugs deepens, researchers and clinicians are uncovering a wealth of potential benefits that span multiple organ systems and disease processes. Let’s explore the exciting pleiotropic effects of incretin mimetics and their implications for future medical treatments.
Cardiovascular Protection: Guarding the Heart
One of the most promising aspects of incretin mimetics is their positive impact on cardiovascular health. Clinical trials have demonstrated that these drugs can significantly reduce major adverse cardiovascular events (MACE), including stroke, myocardial infarction, and cardiovascular death[12]. For instance, a meta-analysis revealed a 12% decrease in MACE and a 9% reduction in heart failure hospitalizations among diabetic patients treated with GLP-1 receptor agonists[12].
The cardioprotective effects of incretin mimetics extend beyond just reducing events. These drugs have been shown to:
Improve endothelial function
Reduce inflammation and oxidative stress in vascular tissues
Enhance cardiac function
Slow the progression of atherosclerosis[12]
Neuroprotection: Shielding the Brain
The potential neuroprotective properties of incretin mimetics have garnered significant attention in recent years. Studies suggest that these drugs may:
Reduce the risk of dementia and Alzheimer’s disease
Improve memory and cognitive function
Protect against neurodegeneration[1]
In animal models of Alzheimer’s disease, incretin-based therapies have demonstrated improvements in cognition, synaptic plasticity, and reductions in amyloid-β levels and tau phosphorylation[8]. These findings open up exciting possibilities for the treatment and prevention of neurodegenerative disorders.
Metabolic Makeover: Beyond Blood Sugar
Incretin mimetics are revolutionizing the treatment of metabolic disorders. Their effects include:
Significant weight loss
Improved insulin sensitivity
Reduction in liver fat content
Potential reversal of early-stage liver fibrosis[7]
The dual GIP/GLP-1 receptor agonist tirzepatide, for example, has shown superior efficacy in glycemic control and weight loss compared to GLP-1 receptor agonists alone[13]. This multi-faceted approach to metabolic health could be a game-changer in combating the obesity epidemic and its associated complications.
Renal Protection: Safeguarding the Kidneys
Emerging evidence suggests that incretin mimetics may have renoprotective effects, including:
Reduction in albuminuria
Slowing of kidney function decline
Potential reduction in the risk of end-stage renal disease[12]
These findings are particularly significant given the high prevalence of kidney disease among patients with diabetes and obesity.
Anti-Inflammatory and Anti-Aging Effects
The pleiotropic effects of incretin mimetics extend to inflammation and aging processes. Studies have shown:
Reduction in oxidative stress and inflammation
Improvement in overall metabolic health
Potential for telomere preservation[12]
While not directly approved for anti-aging purposes, these effects suggest that incretin mimetics could play a role in promoting healthier aging and longevity.
The Road Ahead: Challenges and Opportunities
As we continue to uncover the pleiotropic effects of incretin mimetics, several challenges and opportunities emerge:
Long-term safety: While short-term studies have shown promising results, long-term cardiovascular outcome studies are still ongoing[18].
Cost considerations: These drugs can be expensive, potentially limiting access for some patients[22].
Side effect management: Common side effects like nausea and vomiting need to be addressed to improve patient adherence[22].
Expanding indications: As research progresses, we may see incretin mimetics approved for conditions beyond diabetes and obesity.
Personalized medicine: Understanding individual patient responses to these drugs could help tailor treatments more effectively.
The pleiotropic effects of incretin mimetics represent a new frontier in medicine, offering hope for treating a wide range of age-related and metabolic diseases. As research continues, we may find ourselves on the cusp of a therapeutic revolution, with these versatile drugs playing a central role in promoting health and longevity across multiple organ systems.
While challenges remain, the future looks bright for incretin mimetics. Their ability to address multiple aspects of health simultaneously makes them a powerful tool in our medical arsenal. As we continue to explore their potential, we may discover even more ways in which these remarkable drugs can improve human health and well-being.
Sources [1] Pleiotropic effects of incretins – PMC – PubMed Central https://pmc.ncbi.nlm.nih.gov/articles/PMC3354942/ [2] Exploring the expanding horizons of GLP-1 therapies beyond … https://www.news-medical.net/news/20240718/Exploring-the-expanding-horizons-of-GLP-1-therapies-beyond-diabetes-and-obesity.aspx [3] Twincretin drug Tirzepatide shows unmatched efficacy in weight loss … https://www.news-medical.net/news/20240715/Twincretin-drug-Tirzepatide-shows-unmatched-efficacy-in-weight-loss-and-diabetes-management.aspx [4] Potentials of incretin‐based therapies in dementia and stroke in type … https://pmc.ncbi.nlm.nih.gov/articles/PMC4718099/ [5] Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling … https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2018.00672/full [6] Glucagon-like peptide-1 receptor: mechanisms and advances in … https://www.nature.com/articles/s41392-024-01931-z [7] Tirzepatide is an imbalanced and biased dual GIP and GLP-1 … https://pmc.ncbi.nlm.nih.gov/articles/PMC7526454/ [8] Incretin and insulin signaling as novel therapeutic targets for … https://www.nature.com/articles/s41380-022-01792-4 [9] Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon … https://www.mdpi.com/2079-7737/11/2/288 [10] GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects – Frontiers https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2021.721135/full [11] PATHOPHYSIOLOGICAL ASPECTS OF PLEIOTROPIC EFFECTS … https://pubmed.ncbi.nlm.nih.gov/29889364/ [12] GLP1 Receptor Agonists—Effects beyond Obesity and Diabetes – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC10778154/ [13] Structural insights into multiplexed pharmacological actions of … https://www.nature.com/articles/s41467-022-28683-0 [14] The Influence of Incretin Mimetics on Cardiovascular Risk Factors in … https://pmc.ncbi.nlm.nih.gov/articles/PMC3302114/ 15 Pleiotropic effects of incretins – ResearchGate https://www.researchgate.net/publication/225376004_Pleiotropic_effects_of_incretins [16] GLP1 Receptor Agonists-Effects beyond Obesity and Diabetes https://pubmed.ncbi.nlm.nih.gov/38201269/ [17] Tirzepatide, a novel, dual glucose-dependent insulinotropic … https://www.tandfonline.com/doi/full/10.1080/17512433.2024.2408753 [18] Cardiovascular Biology of the Incretin System – Oxford Academic https://academic.oup.com/edrv/article-abstract/33/2/187/2354957?redirectedFrom=fulltext [19] Strategies for minimizing muscle loss during use of incretin‐mimetic … https://onlinelibrary.wiley.com/doi/10.1111/obr.13841 [20] GLP-1 Receptor Agonists: Beyond Diabetes—What the Neurosurge… https://journals.lww.com/neurosurgpraconline/fulltext/2024/09000/glp_1_receptor_agonists__beyond_diabetes_what_the.6.aspx [21] Effects of Tirzepatide on the Clinical Trajectory of Patients with Heart … https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.124.072679 [22] Incretin mimetics for the management of diabetes and associated … https://www.accscience.com/journal/IMO/articles/online_first/2974 [23] Incretin Therapies: Effects Beyond Glycemic Control https://www.ejinme.com/article/S0953-6205(09)00097-1/pdf [24] GLP-1 receptor agonists beyond diabetes management – The Lancet https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(24)00600-X/fulltext [25] GLP-1 Receptor Agonists for the Reduction of Atherosclerotic … https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059595 [26] The benefits of GLP-1 drugs beyond obesity – Science https://www.science.org/doi/10.1126/science.adn4128 [27] Tirzepatide against obesity and insulin-resistance – PubMed Central https://pmc.ncbi.nlm.nih.gov/articles/PMC11228148/ [28] 12-month effects of incretins versus SGLT2-Inhibitors on cognitive per https://www.dovepress.com/12-month-effects-of-incretins-versus-sglt2-inhibitors-on-cognitive-per-peer-reviewed-fulltext-article-CPAA
Lysine is an essential amino acid that plays a crucial role in numerous physiological processes within the human body. As a building block for proteins, lysine is vital for growth, tissue repair, and the production of enzymes, hormones, and antibodies. While lysine deficiency is rare in developed countries, supplementation may offer various health benefits, particularly for individuals with specific health conditions or dietary restrictions. This article explores the wide-ranging benefits of lysine, backed by scientific evidence, and discusses its potential impact on metabolic health and overall well-being.
Immune System Support and Herpes Management
One of the most well-established benefits of lysine is its role in supporting the immune system and managing herpes simplex virus (HSV) infections. Lysine has been shown to have antiviral properties, particularly against HSV-1 and HSV-2, which cause cold sores and genital herpes, respectively[1]. The mechanism behind this effect is thought to be lysine’s ability to interfere with the replication of the herpes virus by competing with arginine, an amino acid that promotes viral growth[5].
Clinical studies have demonstrated that lysine supplementation can reduce the frequency, severity, and duration of herpes outbreaks. For instance, a study found that taking 1000-3000 mg of lysine daily may help prevent cold sore recurrence and accelerate healing time[1]. While more research is needed to establish optimal dosing, these findings suggest that lysine supplementation could be a valuable adjunct therapy for individuals prone to herpes infections.
Calcium Absorption and Bone Health
Lysine plays a significant role in calcium metabolism and bone health. Research has shown that lysine enhances intestinal calcium absorption and improves renal conservation of the absorbed calcium[12]. This dual action of lysine on calcium metabolism suggests potential benefits for bone health, particularly in the context of osteoporosis prevention and management.
A study investigating the effects of lysine supplementation on calcium metabolism in humans found that lysine can both enhance intestinal calcium absorption and improve the renal conservation of absorbed calcium[12]. These effects may contribute to a positive calcium balance, suggesting potential usefulness of lysine supplements for both preventive and therapeutic interventions in osteoporosis.
Muscle Growth and Athletic Performance
Lysine is essential for muscle protein synthesis and repair, making it a nutrient of interest for athletes and individuals engaged in regular physical activity. As a precursor to carnitine, lysine plays a role in fatty acid metabolism and energy production in muscle cells[1][7].
Research has shown that lysine supplementation may help with muscle loss and enhance strength, particularly in older adults. A study found that consuming 80 mg/kg of lysine daily for 8 weeks improved muscle strength in the forearm by about 7.5% in young men[13]. While more research is needed to fully elucidate the effects of lysine on muscle growth and athletic performance, these findings suggest potential benefits for both athletes and aging populations.
Anxiety Reduction and Stress Management
Emerging research indicates that lysine may have anxiolytic properties and could play a role in stress management. A study conducted in economically weak populations consuming cereal-based diets found that lysine fortification reduced chronic anxiety in males, as measured by the trait anxiety inventory[27]. The same study also observed reduced cortisol response to stress in females and decreased sympathetic arousal in males following lysine fortification[27].
The mechanism behind lysine’s anxiolytic effects is not fully understood but may involve its interaction with serotonin receptors and the benzodiazepine system[27]. These findings suggest that lysine supplementation could be a potential nutritional strategy for managing stress and anxiety, particularly in populations with inadequate lysine intake.
Wound Healing and Collagen Formation
Lysine is crucial for the formation of collagen, a protein that provides structure to skin, bones, and connective tissues. This role in collagen synthesis makes lysine important for wound healing and tissue repair[1][5]. Studies have shown that lysine supplementation can enhance wound healing by promoting collagen formation and increasing the number of new cells in a wound[5].
While most research on lysine’s role in wound healing has been conducted in animal models, the results are promising and suggest potential benefits for humans, particularly in cases of slow-healing wounds or surgical recovery.
Metabolic Health and Diabetes Management
Recent research has begun to explore lysine’s potential impact on metabolic health, particularly in relation to diabetes management. Some studies suggest that lysine may help regulate blood sugar levels, although more research is needed to confirm these effects[5][15].
A small study found that lysine supplementation may improve glycemic control and reduce the progression of diabetes[18]. The mechanism behind this potential benefit is not fully understood but may involve lysine’s role in protein synthesis and its effects on insulin secretion and glucose metabolism.
Cardiovascular Health
Lysine may also have benefits for cardiovascular health. Some research suggests that lysine supplementation could help lower blood pressure and reduce inflammation in the arteries[1][5]. Additionally, lysine may play a role in preventing blood clots by inhibiting the accumulation of lipoprotein(a), a type of cholesterol associated with increased risk of cardiovascular disease[1].
While these findings are promising, more large-scale clinical trials are needed to fully establish lysine’s role in cardiovascular health and determine optimal dosing for these potential benefits.
Conclusion
Lysine, an essential amino acid, offers a wide array of potential health benefits, from supporting immune function and managing herpes infections to promoting bone health, muscle growth, and potentially impacting metabolic and cardiovascular health. While many of these benefits are supported by scientific evidence, it’s important to note that research is ongoing, and optimal dosing and long-term effects of lysine supplementation require further investigation.
For healthcare providers, understanding the multifaceted roles of lysine in human physiology can inform nutritional recommendations and potential therapeutic strategies. For the general public, ensuring adequate lysine intake through diet or, when necessary, supplementation under medical supervision, may contribute to overall health and well-being.
As with any nutritional intervention, individual needs may vary, and potential interactions with medications or existing health conditions should be considered. Always consult with a healthcare professional before starting any new supplement regimen.
[1][2][5][7][12][13][15][18][27]
Sources [1] Top 6 Health Benefits of Lysine – GOOD IDEA Drink https://www.goodidea.us/blogs/dr-elins-blog/benefits-of-lysine [2] Effect of lysine supplementation on health and morbidity in subjects … https://pubmed.ncbi.nlm.nih.gov/20720257/ [3] What Is L-Lysine Good For? 10 Health Benefits – MedicineNet https://www.medicinenet.com/what_is_l-lysine_good_for/article.htm [4] l-Lysine supplementation affects dietary protein quality and growth … https://pmc.ncbi.nlm.nih.gov/articles/PMC10651908/ [5] 4 Impressive Health Benefits of Lysine – Healthline https://www.healthline.com/nutrition/lysine-benefits [6] Integrative physiology of lysine metabolites – PubMed https://pubmed.ncbi.nlm.nih.gov/37781739/ [7] Learn About Lysine Health Benefits – Cooper Complete https://coopercomplete.com/blog/lysine-benefits-should-you-take-lysine/ [8] LYSINE – Uses, Side Effects, and More – WebMD https://www.webmd.com/vitamins/ai/ingredientmono-237/lysine [9] Lysine health benefits: Evidence and food sources https://www.medicalnewstoday.com/articles/324019 [10] Lysine – University of Rochester Medical Center https://www.urmc.rochester.edu/encyclopedia/content?contenttypeid=19&contentid=Lysine [11] Lysine: Benefits, Uses, Side Effects, and More – Health https://www.health.com/lysine-benefits-7106132 [12] Dietary L-lysine and calcium metabolism in humans – PubMed https://pubmed.ncbi.nlm.nih.gov/1486246/ [13] Lysine: Health Benefits, Side Effects, Uses, Dose & Precautions https://www.rxlist.com/supplements/lysine.htm [14] 4 Impressive Health Benefits of Lysine – Healthline https://www.healthline.com/nutrition/lysine-benefits [15] Lysine Information | Mount Sinai – New York https://www.mountsinai.org/health-library/supplement/lysine [16] L-lysine dietary supplementation for childhood and adolescent growth https://www.sciencedirect.com/science/article/pii/S2090123224002029 [17] Review of Lysine Metabolism with a Focus on Humans – PubMed https://pubmed.ncbi.nlm.nih.gov/33000162/ [18] Lysine health benefits: Evidence and food sources https://www.medicalnewstoday.com/articles/324019 19 Medicinal Uses of L-Lysine: Past and Future – ResearchGate https://www.researchgate.net/publication/267817166_Medicinal_Uses_of_L-Lysine_Past_and_Future [20] The Association of the Essential Amino Acids Lysine, Methionine … https://www.mdpi.com/2072-6643/16/16/2608 [21] Inherited Disorders of Lysine Metabolism: A Review – ScienceDirect https://www.sciencedirect.com/science/article/pii/S0022316622024245 [22] Comprehensive Safety Assessment of ʟ-Lysine Supplementation … https://jn.nutrition.org/article/S0022-3166(22)02431-2/fulltext [23] Integrative physiology of lysine metabolites https://journals.physiology.org/doi/full/10.1152/physiolgenomics.00061.2023 [24] Comprehensive Safety Assessment of L-Lysine Supplementation … https://jn.nutrition.org/article/S0022-3166(22)02431-2/pdf [25] Review of Lysine Metabolism with a Focus on Humans https://jn.nutrition.org/article/S0022-3166(22)02432-4/pdf [26] Adaptive regulation of intestinal lysine metabolism – PNAS https://www.pnas.org/doi/10.1073/pnas.200371497 [27] Lysine fortification reduces anxiety and lessens stress in family … https://pmc.ncbi.nlm.nih.gov/articles/PMC420386/ [28] l-Lysine supplementation affects dietary protein quality and growth … https://www.nature.com/articles/s41598-023-47321-3 [29] Dietary Lysine Regulates Body Growth Performance via the Nutrient … https://www.frontiersin.org/journals/marine-science/articles/10.3389/fmars.2020.595682/full [30] Comprehensive Safety Assessment of l-Lysine Supplementation … https://pubmed.ncbi.nlm.nih.gov/33000161/
As parents, we all want our children to live long, healthy lives. While there’s no guarantee of reaching centenarian status, there are many evidence-based interventions we can implement to give our kids the best shot at longevity. This guide explores key areas where parents can make a difference, from nutrition and lifestyle choices to disease prevention and safety.
Nutrition: Building Blocks for a Long Life
Whole Foods vs. Processed Foods
A diet rich in whole, unprocessed foods forms the foundation of longevity nutrition. Research has shown that ultra-processed foods are associated with numerous health risks:
A systematic review found that higher consumption of ultra-processed foods was linked to increased risks of overweight, obesity, abdominal obesity, all-cause mortality, metabolic syndrome, depression, and various cancers[1].
Ultra-processed food intake was associated with a 62% increased risk of all-cause mortality in a study of nearly 20,000 Spanish university graduates[1].
A meta-analysis found that higher ultra-processed food intake was associated with increased risk of type 2 diabetes[1].
To promote longevity, encourage your children to eat:
Fruits and vegetables: Aim for 5 servings daily, focusing on a variety of colors.
Whole grains: Choose brown rice, whole wheat bread, and oats over refined grains.
Lean proteins: Include fish, poultry, legumes, and nuts.
Healthy fats: Incorporate sources of unsaturated fats like avocados, olive oil, and fatty fish.
Foods to Limit or Avoid
Equally important is minimizing foods that can negatively impact health:
Processed meats: Hot dogs, deli meats, and sausages are high in sodium and preservatives.
Sugary drinks: Sodas, fruit juices, and sports drinks provide empty calories.
Artificial sweeteners: These can potentially lead to metabolic issues.
Fried foods: High in unhealthy fats, they increase heart disease risk.
High-sugar cereals: Opt for low-sugar, whole-grain alternatives.
The Dangers of Artificial Sweeteners and Fructose
While artificial sweeteners may seem like a healthy alternative to sugar, research suggests otherwise:
A systematic review found that artificial sweetener consumption was associated with increased risk of type 2 diabetes, cardiovascular disease, and metabolic syndrome[2].
Frequent consumption of artificial sweeteners may lead to metabolic derangements and, paradoxically, weight gain[2].
Fructose, especially in the form of high-fructose corn syrup, has been linked to various health issues:
Excessive fructose intake is associated with increased risk of obesity, diabetes, and non-alcoholic fatty liver disease[3].
Preserved Foods and Cancer Risk
Studies, particularly from Asia, have shown associations between preserved foods and cancer risk:
A meta-analysis found a 52% higher risk of gastric cancer associated with intake of pickled vegetables/foods, with stronger associations in Korea and China[4].
Consumption of cured meat was significantly associated with increased breast cancer risk in Hong Kong Chinese women[4].
Physical Activity: Moving Towards Longevity
Regular physical activity is crucial for long-term health. The Centers for Disease Control and Prevention (CDC) provides clear guidelines:
Children and adolescents ages 6 through 17 years should do 60 minutes or more of moderate-to-vigorous physical activity daily[5].
This should include:
Aerobic activity: Most of the 60 minutes
Muscle-strengthening: At least 3 days per week
Bone-strengthening: At least 3 days per week
Encouraging active play, participation in sports, and limiting screen time can help children meet these goals.
Discouraging Illicit Drug Use and Risky Behaviors
Tobacco and Alcohol Prevention
Tobacco use remains a significant health threat to young people. In 2023, 10.0% of middle and high school students reported current use of any tobacco product[6]. To help prevent tobacco use:
Start conversations early: Begin discussing the dangers of tobacco use when children are 5-7 years old.
Be a role model: If you smoke, quit. Children of non-smoking parents are less likely to start smoking.
Establish clear rules: Set firm expectations about not using tobacco and enforce consequences.
Educate about industry tactics: Teach children to recognize and resist tobacco marketing strategies.
Alcohol remains the most commonly used substance among adolescents. In 2023, about 19.9% of youth ages 14 to 15 reported having at least one drink in their lifetime[6]. To discourage underage drinking:
Communicate openly: Discuss the risks of alcohol use and your expectations regularly.
Set a good example: Model responsible alcohol use or abstinence.
Monitor activities: Know where your children are and who they’re with, especially during teen years.
Strengthen family bonds: Regular family activities and open communication can reduce the likelihood of substance use.
Preventing Opioid Misuse
The opioid epidemic has had devastating effects on communities across the United States. To help prevent opioid misuse among youth:
Educate about risks: Discuss the dangers of prescription opioid misuse and illicit opioid use.
Secure medications: Keep prescription medications, especially opioids, locked away and dispose of unused medications properly.
Promote alternative pain management: Encourage non-opioid pain management strategies when appropriate.
Support mental health: Address underlying mental health issues that may contribute to substance use.
Disease Prevention
Cancer Prevention
While not all childhood cancers are preventable, certain strategies can reduce future risk:
Sun protection: Use sunscreen, protective clothing, and limit sun exposure.
Healthy diet: Emphasize fruits, vegetables, and whole grains.
Physical activity: Maintain a healthy weight through regular exercise.
Vaccinations: Ensure children receive HPV and Hepatitis B vaccines.
Avoid tobacco exposure: Don’t smoke and avoid secondhand smoke.
Vitamin D and Cancer Risk
Vitamin D has been the subject of numerous studies regarding its potential role in cancer prevention:
A large clinical trial (VITAL) found that vitamin D supplementation reduced the incidence of advanced (metastatic or fatal) cancer, with the strongest risk reduction seen in individuals with normal weight[7].
Higher circulating levels of vitamin D (25-hydroxyvitamin D) have been associated with reduced risk of colorectal and bladder cancers[7].
The current evidence suggests that maintaining adequate vitamin D levels may be beneficial for cancer prevention, but more research is needed to establish definitive recommendations. The National Academy of Sciences recommends daily vitamin D intakes of 600 IU for most age groups[7].
Heart Disease Prevention
Heart health in adulthood starts in childhood:
Encourage a heart-healthy diet low in saturated fats and high in fruits, vegetables, and whole grains.
Promote regular physical activity.
Maintain a healthy weight.
Monitor blood pressure and cholesterol if there’s a family history of heart disease.
Safety and Accident Prevention
Accidents are a leading cause of childhood mortality. Key safety measures include:
Use appropriate car seats and teach road safety.
Childproof your home to prevent falls, poisonings, and choking hazards.
Teach water safety and ensure proper supervision around water.
Store medications and household chemicals safely out of reach.
Ensure proper helmet use for biking and other wheeled activities.
Conclusion
Helping our children live long, healthy lives involves a multifaceted approach encompassing nutrition, physical activity, disease prevention, safety, and overall lifestyle choices. By implementing these evidence-based strategies early in life, we can set our children on a path towards optimal health and longevity.
Remember, it’s never too early to start these healthy habits, but it’s also never too late. Small, consistent changes can make a big difference over time. As parents, we have the power to shape our children’s health trajectories. Let’s use that power wisely to give them the best possible start in life.
Sources [1] Youth High-Risk Drug Use – CDC https://www.cdc.gov/youth-behavior/risk-behaviors/youth-high-risk-drug-use.html [2] [PDF] Promising School-based Opioid Prevention Approaches https://www.escneo.org/Downloads/SAMHSA%20Opioid%20Brief.pdf [3] 6 Ideas for Reducing Risky Behaviors in Teens https://prntexas.org/6-ideas-for-reducing-risky-behaviors-in-teens/ [4] Dietary Recommendations for Healthy Children https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/nutrition-basics/dietary-recommendations-for-healthy-children [5] Physical Activity Guidelines for School-Aged Children and … https://www.floridanutritioned.org/tip/physical-activity-guidelines-for-school-aged-children-and-adolescents/ [6] Managing Infectious Diseases in Schools – AAP https://www.aap.org/en/patient-care/school-health/managing-infectious-diseases-in-schools/ [7] Evidence-Based Interventions for Preventing Substance Use … https://pmc.ncbi.nlm.nih.gov/articles/PMC2916744/ [8] Invest in Youth Prevention | Opioid Principles https://opioidprinciples.jhsph.edu/invest-in-youth-prevention/ [9] Strategies to Prevent Risk, Promote Health in Teens https://parentandteen.com/coping-strategies-prevent-risk/ [10] Evidence-Based Recommendations and Best Practices for … https://healthyeatingresearch.org/research/evidence-based-recommendations-and-best-practices-for-promoting-healthy-eating-behaviors-in-children-2-to-8-years/ [11] Physical Activity Guidelines for School-Aged Children and … – CDC https://www.cdc.gov/physical-activity-education/guidelines/index.html [12] Preventing Infectious Diseases | Early Care and Education Portal https://www.cdc.gov/early-care/prevention/index.html [13] Interventions to Prevent Illicit and Nonmedical Drug Use in Children … https://jamanetwork.com/journals/jama/fullarticle/2766429 [14] Effectiveness of Nutritional Strategies on Improving the Quality of … https://pmc.ncbi.nlm.nih.gov/articles/PMC8781853/ [15] Youth Opioid Prevention – Boys & Girls Clubs of America https://www.bgca.org/get-involved/advocacy/federal-priorities/youth-opioid-prevention/ [16] Preventing Multiple Risky Behaviors Among Adolescents https://www.childtrends.org/publications/preventing-multiple-risky-behaviors-among-adolescents-seven-strategies [17] Effective Ways to Stop Substance Abuse https://www.schoolcounselor.org/Newsletters/May-2023/Effective-Ways-to-Stop-Substance-Abuse?st=WA [18] State Strategies for Preventing Substance Use and Overdose … https://nashp.org/state-strategies-for-preventing-substance-use-and-overdose-among-youth-and-adolescents/ [19] [PDF] A Health Promotion Strategy to Preventing Youth Risk Behaviors https://teenpregnancy.acf.hhs.gov/sites/default/files/resource-files/SocialNorms_Denise%20Dickinson.pdf [20] [PDF] Preventing Drug Use Among Children and Adolescents (Redbook) https://nida.nih.gov/sites/default/files/redbook_0.pdf [21] Opioid Abuse Prevention – Ohio Department of Education https://education.ohio.gov/Topics/Learning-in-Ohio/Health-Education/Opioid-Abuse-Prevention [22] Risky behaviour: pre-teens and teenagers – Raising Children Network https://raisingchildren.net.au/teens/behaviour/behaviour-questions-issues/risky-behaviour [23] Preventing and Reducing Youth and Young Adult Substance Misuse https://www.ed.gov/teaching-and-administration/safe-learning-environments/school-safety-and-security/preventing-and-reducing-youth-and-young-adult-substance-misuse-schools-students-families [24] Preventing Opioid Use Disorder | Overdose Prevention – CDC https://www.cdc.gov/overdose-prevention/prevention/preventing-opioid-use-disorder.html [25] Reducing Risk Behavior With Family-Centered Prevention During … https://pmc.ncbi.nlm.nih.gov/articles/PMC6310108/ [26] Tips for Preventing Youth Addiction – Delaware County, Pennsylvania https://www.delcopa.gov/substance/tipsforprevention.html [27] Preventing risky behaviors among young adolescents in eastern … https://pmc.ncbi.nlm.nih.gov/articles/PMC6261778/ 28 Preventing Multiple Risky Behaviors among Adolescents https://www.researchgate.net/publication/265111039_Preventing_Multiple_Risky_Behaviors_among_Adolescents_Seven_Strategies [29] [PDF] PHYSICAL ACTIVITY IN CHILDREN AND ADOLESCENTS https://www.acsm.org/docs/default-source/files-for-resource-library/physical-activity-in-children-and-adolescents.pdf [30] Disease Prevention and Health Promotion | City of Berkeley https://berkeleyca.gov/safety-health/public-health/disease-prevention-and-health-promotion [31] Effectiveness of Nutritional Strategies on Improving the Quality of … https://pubmed.ncbi.nlm.nih.gov/35057552/ [32] Physical activity guidelines for children and young people – NHS https://www.nhs.uk/live-well/exercise/physical-activity-guidelines-children-and-young-people/ [33] Everyday Actions for Schools to Prevent and Control the Spread of … https://www.cdc.gov/orr/school-preparedness/infection-prevention/actions.html [34] How to teach kids healthy eating habits: Dietitian’s 10 tips https://engagement.source.colostate.edu/research-based-tips-mealtime-success-kids/ [35] [PDF] Physical Activity Guidelines for Americans, 2nd edition https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf [36] Prevention of noncommunicable diseases https://www.who.int/teams/maternal-newborn-child-adolescent-health-and-ageing/child-health/prevention-of-noncommunicable-diseases [37] Nutrition for kids: Guidelines for a healthy diet – Mayo Clinic https://www.mayoclinic.org/healthy-lifestyle/childrens-health/in-depth/nutrition-for-kids/art-20049335 [38] 2020 WHO guidelines on physical activity and sedentary behaviour … https://pmc.ncbi.nlm.nih.gov/articles/PMC7691077/ [39] Protecting Your Child From Infections – MyHealth Alberta https://myhealth.alberta.ca/Health/pages/conditions.aspx?hwid=ue5130 [40] American Heart Association Recommendations for Physical Activity … https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-kids-infographic [41] Children – Healthy People 2030 | odphp.health.gov https://odphp.health.gov/healthypeople/objectives-and-data/browse-objectives/children [42] Child Activity: An Overview | Physical Activity Basics – CDC https://www.cdc.gov/physical-activity-basics/media/images/Kidsrunning169.jpg?sa=X&ved=2ahUKEwiVzqGFv-6KAxX7G9AFHW6jHkYQ_B16BAgDEAI [43] Reducing the Spread of Illness in Child Care – HealthyChildren.org https://www.healthychildren.org/English/health-issues/conditions/prevention/Pages/Prevention-In-Child-Care-or-School.aspx
As cardiovascular disease remains a leading cause of morbidity and mortality worldwide, optimizing lipid management is crucial for reducing atherosclerotic cardiovascular disease (ASCVD) risk. While statins are the cornerstone of lipid-lowering therapy, many patients require additional interventions to achieve target lipid levels or may not tolerate statins. This review examines the evidence for non-statin lipid-lowering therapies, including pharmacological agents, nutraceuticals, and dietary interventions.
Importance of MACE Data
When evaluating lipid-lowering therapies, it’s critical to focus on major adverse cardiovascular events (MACE) data rather than solely on lipid level changes. MACE typically includes a composite of cardiovascular death, non-fatal myocardial infarction (“heart attack”) and non-fatal stroke. Some studies also include hospitalization for unstable angina or coronary revascularization[13] (procedure to open clogged vessels). MACE endpoints provide a more clinically relevant measure of a therapy’s impact on patient outcomes compared to surrogate markers like LDL-C levels alone.
Pharmacological Agents
Ezetimibe
Mechanism: Ezetimibe inhibits intestinal cholesterol absorption by targeting the Niemann-Pick C1-Like 1 (NPC1L1) protein[5].
Efficacy: Ezetimibe typically reduces LDL-C by 15-20% when used as monotherapy (used alonea) and provides an additional 23-24% reduction when added to statin therapy[5][23].
Outcomes: The IMPROVE-IT trial demonstrated that adding ezetimibe to simvastatin in patients with recent acute coronary syndrome (emergency when blood flow to heart is reduced) reduced LDL-C by 24% and lowered the risk of cardiovascular events by 6.4% over 7 years[28].
Pleiotropic effects (not the primary effect or intention of drug) : Some studies suggest ezetimibe may have anti-inflammatory properties and improve endothelial function, though these effects are less well-established than for statins[42].
Bempedoic Acid
Mechanism: Bempedoic acid inhibits ATP citrate lyase (ACL), reducing cholesterol synthesis upstream of HMG-CoA reductase[21].
Efficacy: In statin-intolerant patients, bempedoic acid reduces LDL-C by 21% compared to placebo[21].
Outcomes: The CLEAR Outcomes trial showed a 13% relative reduction in MACE with bempedoic acid in statin-intolerant patients[21].
Pleiotropic effects: Bempedoic acid may have anti-inflammatory properties, as evidenced by reductions in high-sensitivity C-reactive protein (hsCRP)[21].
Colesevelam
Mechanism: Colesevelam is a bile acid sequestrant that binds bile acids in the intestine, leading to increased bile acid excretion and upregulation of LDL receptors[27].
Efficacy: Colesevelam reduces LDL-C by 15-18% as monotherapy and provides an additional 8-16% reduction when added to statin therapy[27].
Outcomes: While colesevelam improves lipid profiles, large-scale cardiovascular outcome trials are lacking[27].
Pleiotropic effects: Colesevelam has been shown to improve glycemic control in patients with type 2 diabetes, reducing HbA1c by 0.5-0.8%[22][41].
PCSK9 Inhibitors
Mechanism: PCSK9 inhibitors are monoclonal antibodies that prevent PCSK9-mediated degradation of LDL receptors, increasing LDL-C clearance from the bloodstream[40].
Efficacy: PCSK9 inhibitors can reduce LDL-C by 50-60% when added to statin therapy[40].
Outcomes: The FOURIER and ODYSSEY OUTCOMES trials demonstrated significant reductions in MACE with evolocumab and alirocumab, respectively, when added to statin therapy in high-risk patients[40].
Pleiotropic effects: PCSK9 inhibitors may have anti-inflammatory effects and improve endothelial function, though more research is needed to confirm these potential benefits[40].
Nutraceuticals and Supplements
Red Yeast Rice
Mechanism: Red yeast rice contains monacolin K, which is structurally identical to lovastatin and inhibits HMG-CoA reductase[19][24].
Efficacy: Red yeast rice can reduce LDL-C by 15-25% depending on the monacolin K content[19][24].
Outcomes: A meta-analysis of red yeast rice trials showed a 34% reduction in MACE and a 40% reduction in composite cardiac events[24].
Safety concerns: The FDA does not regulate red yeast rice products, leading to variability in monacolin K content and potential contamination with citrinin, a nephrotoxic mycotoxin[19].
Plant Sterols and Stanols
Mechanism: Plant sterols and stanols compete with cholesterol for intestinal absorption, reducing cholesterol uptake[6].
Efficacy: Consuming 2 grams of plant sterols or stanols daily can lower LDL-C by 5-15%[6][47].
Outcomes: While plant sterols and stanols improve lipid profiles, large-scale cardiovascular outcome trials are lacking[6].
Soluble Fiber
Mechanism: Soluble fiber binds bile acids in the intestine, leading to increased bile acid excretion and upregulation of LDL receptors[47].
Efficacy: Consuming 5-10 grams of soluble fiber daily can reduce LDL-C by 5-10%[47][49].
Outcomes: While soluble fiber improves lipid profiles, its direct impact on MACE has not been established in large-scale trials[49].
Efficacy: High-dose omega-3 fatty acids (4 grams daily) can reduce triglycerides by 30-50%[53].
Outcomes: The REDUCE-IT trial demonstrated a 25% relative risk reduction in MACE with 4 grams of icosapent ethyl (a highly purified EPA) in high-risk patients with elevated triglycerides[53].
Other Supplements
Several other supplements have shown potential lipid-lowering effects, though evidence for cardiovascular benefit is limited:
Berberine: May reduce LDL-C by 20-30%[10]
Garlic extract: May modestly reduce total cholesterol and LDL-C[10]
Green tea extract: May have modest LDL-C lowering effects[10]
Niacin: Can increase HDL-C and lower triglycerides, but has not shown cardiovascular benefit in recent trials[53]
Dietary Interventions
Mediterranean Diet
The Mediterranean diet, characterized by high consumption of olive oil, fruits, vegetables, whole grains, and moderate consumption of fish and poultry, has been associated with improved cardiovascular outcomes[47][56].
Efficacy: While the direct impact on lipid levels varies, adherence to a Mediterranean diet has been associated with a 30% reduction in MACE in high-risk individuals[47].
Plant-Based Diets
Vegetarian and vegan diets have been shown to improve lipid profiles and may reduce cardiovascular risk[52].
Efficacy: A meta-analysis of randomized controlled trials found that vegetarian and vegan diets reduced total cholesterol by 7%, LDL-C by 10%, and apolipoprotein B by 14% compared to omnivorous diets[52].
Portfolio Diet
The Portfolio Diet combines several cholesterol-lowering foods, including plant sterols, soy protein, viscous fibers, and nuts[49].
Efficacy: The Portfolio Diet has been shown to reduce LDL-C by 20-30%, comparable to the effect of a low-dose statin[49].
Other Dietary Strategies
Replacing saturated fats with unsaturated fats can reduce LDL-C by 9-16%[47][49]
Increasing intake of fruits and vegetables may modestly improve lipid profiles[47]
Consuming 1.5-2 ounces of tree nuts daily can reduce LDL-C by 3-5%[49]
Conclusion
While statins remain the cornerstone of lipid-lowering therapy, a wide array of non-statin interventions can effectively improve lipid profiles and reduce cardiovascular risk. When selecting therapies, physicians should consider the strength of evidence for MACE reduction, individual patient characteristics, and potential pleiotropic effects. Combining pharmacological agents with evidence-based dietary interventions and nutraceuticals may provide additive benefits in managing dyslipidemia and reducing ASCVD risk.
As our understanding of lipid metabolism and cardiovascular disease continues to evolve, ongoing research into novel therapies and combinations will further refine our approach to lipid management. Physicians should stay informed about emerging evidence and guidelines to provide optimal care for patients at risk for ASCVD.
Sources [1] Pleiotropic effects of statin therapy: molecular mechanisms and … https://pmc.ncbi.nlm.nih.gov/articles/PMC2621332/ [2] Colesevelam for the treatment of bile acid malabsorption-associated … https://academic.oup.com/ecco-jcc/article-abstract/8/11/1471/356826?redirectedFrom=fulltext&login=false [3] Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic … https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.118.039415 [4] Red Yeast Rice for Hypercholesterolemia – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC6822657/ [5] Use of lipid-lowering therapy: the guidelines, the drugs or the patient? https://academic.oup.com/eurheartjsupp/article/24/Supplement_I/I29/6823824?login=false [6] [PDF] Nutrition Interventions for Adults with Dyslipidemia https://www.lipid.org/sites/default/files/files/NLA_2023_Nutrition_Interventions_for_Adults_with_Dyslipidemia.pdf [7] 11 Foods that Lower Cholesterol – Harvard Health Publishing https://www.health.harvard.edu/heart-health/11-foods-that-lower-cholesterol [8] Impact of Mediterranean Diet on Lipid Composition in the Colaus … https://pmc.ncbi.nlm.nih.gov/articles/PMC10650561/ [9] Effects of a Plant-Based Diet on Plasma Lipids – Stanford Medicine https://med.stanford.edu/nutrition/research/completed-studies/plant-based-diet.html [10] Supplements for Lipid Lowering: What Does the Evidence Show? https://pubmed.ncbi.nlm.nih.gov/37300664/ [11] Residual Risk Factors to Predict Major Adverse Cardiovascular … https://www.nature.com/articles/s41598-017-08741-0 [12] Cardiovascular benefits of lipid-lowering drugs apply across … https://www.escardio.org/The-ESC/Press-Office/Press-releases/cardiovascular-benefits-of-lipid-lowering-drugs-apply-across-ethnicities-and-reg [13] Major adverse cardiovascular events – Wikipedia https://en.wikipedia.org/wiki/Major_adverse_cardiovascular_events [14] Optimization of the MACE endpoint composition to increase power … https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1242845/full [15] Intensity of and Adherence to Lipid‐Lowering Therapy as Predictors … https://www.ahajournals.org/doi/10.1161/JAHA.122.025813 [16] Understanding the molecular mechanisms of statin pleiotropic effects https://pmc.ncbi.nlm.nih.gov/articles/PMC10119541/ [17] Safety and Efficacy of Colesevelam HCl in the Treatment of Elderly … https://pmc.ncbi.nlm.nih.gov/articles/PMC4033819/ [18] Ezetimibe: The Lower the LDL-C, the Better (Even for Total … https://www.acc.org/Latest-in-Cardiology/Articles/2016/03/09/06/50/Ezetimibe-The-Lower-the-LDLC-the-Better [19] Red Yeast Rice for the Improvement of Lipid Profiles in Mild-to … https://pmc.ncbi.nlm.nih.gov/articles/PMC10221652/ [20] New drugs coming up in the field of lipid control https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-19/new-drugs-coming-up-in-the-field-of-lipid-control [21] Comparative Cardiovascular Benefits of Bempedoic Acid and Statin … https://www.jacc.org/doi/10.1016/j.jacc.2024.04.048 [22] Efficacy and Safety of Colesevelam in Patients With Type 2 Diabetes … https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/770320 [23] Ezetimibe therapy: mechanism of action and clinical update – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC3402055/ [24] Red Yeast Rice Preparations Reduce Mortality, Major … – Frontiers https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2022.744928/full [25] A historical, evidence-based, and narrative review on commonly … https://www.jlr.org/article/S0022-2275(23)00166-9/fulltext [26] Statin effects beyond lipid lowering—are they clinically relevant? https://academic.oup.com/eurheartj/article/24/3/225/2733886?login=false [27] Colesevelam hydrochloride: evidence for its use in the treatment of … https://pmc.ncbi.nlm.nih.gov/articles/PMC3426253/ [28] Ezetimibe – StatPearls – NCBI Bookshelf https://www.ncbi.nlm.nih.gov/books/NBK532879/ [29] Red Yeast Rice for Hyperlipidemia: A Meta-Analysis of 15 High … https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.819482/full [30] Lipid-Lowering Therapies: A Review of Current and Future Options https://www.uspharmacist.com/article/lipidlowering-therapies-a-review-of-current-and-future-options [31] The Pleiotropic Effects of Lipid-Modifying Interventions – MDPI https://www.mdpi.com/2218-1989/14/7/388 [32] Colesevelam Hydrochloride (Cholestagel): A New, Potent Bile Acid … https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/485105 [33] New Insights on Simvastatin and Ezetimibe in a Single Tablet https://www.ecrjournal.com/articles/new-insights-simvastatin-and-ezetimibe-single-tablet [34] Red yeast rice Information | Mount Sinai – New York https://www.mountsinai.org/health-library/supplement/red-yeast-rice [35] Lipid-Lowering Agents | Circulation Research – AHA Journals https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313171 [36] Pleiotropic Effects of Statins on the Cardiovascular System https://www.ahajournals.org/doi/10.1161/circresaha.116.308537 [37] a double-blind, randomised, placebo-controlled, phase 4 clinical trial https://www.thelancet.com/journals/langas/article/PIIS2468-1253(22)00401-0/fulltext?dgcid=raven_jbs_aip_email [38] Projected Outcomes of Optimized Statin and Ezetimibe Therapy in … https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808802 [39] Efficacy of red yeast rice extract on myocardial infarction patients … https://www.nature.com/articles/s41598-020-59796-5 [40] Nonstatin Low-Density Lipoprotein–Lowering Therapy and … https://www.ahajournals.org/doi/10.1161/atvbaha.115.306442 [41] Colesevelam lowers glucose and lipid levels in type 2 diabetes https://dom-pubs.onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1463-1326.2009.01181.x [42] Ezetimibe: cholesterol lowering and beyond – Taylor & Francis Online https://www.tandfonline.com/doi/full/10.1586/14779072.6.4.447 [43] Red Yeast Rice for Hypercholesterolemia: JACC Focus Seminar https://www.jacc.org/doi/abs/10.1016/j.jacc.2020.11.056 [44] Are We Using Ezetimibe As Much As We Should? – Sage Journals https://journals.sagepub.com/doi/10.1177/11772719241257410 [45] [PDF] Dietary intervention to lower serum cholesterol – RACGP https://www.racgp.org.au/getattachment/f8f6c03d-08b4-49b1-abb4-35039b0f4928/Lower-serum-cholesterol.aspx [46] How to Lower Cholesterol with Diet – MedlinePlus https://medlineplus.gov/howtolowercholesterolwithdiet.html [47] Does the Mediterranean Diet Have Any Effect on Lipid Profile … https://pmc.ncbi.nlm.nih.gov/articles/PMC10222807/ [48] Vegetarian and vegan diets may lower cholesterol levels https://www.health.harvard.edu/heart-health/vegetarian-and-vegan-diets-may-lower-cholesterol-levels [49] Diet and Exercise in the Management of Hyperlipidemia – AAFP https://www.aafp.org/pubs/afp/issues/2010/0501/p1097.html [50] Cholesterol – healthy eating tips – Better Health Channel https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/cholesterol-healthy-eating-tips [51] LDL cholesterol: Mediterranean diet may not affect levels https://www.medicalnewstoday.com/articles/does-a-mediterranean-diet-really-help-lower-bad-cholesterol [52] Vegetarian or vegan diets and blood lipids: a meta-analysis of … https://pubmed.ncbi.nlm.nih.gov/37226630/ [53] Alternative Treatments for High Cholesterol – WebMD https://www.webmd.com/cholesterol-management/high-cholesterol-alternative-therapies [54] Association between Dietary Intake and Lipid-Lowering Therapy https://pmc.ncbi.nlm.nih.gov/articles/PMC6724025/ [55] Prevention and Treatment of High Cholesterol (Hyperlipidemia) https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia [56] Mediterranean diet: MedlinePlus Medical Encyclopedia https://medlineplus.gov/ency/patientinstructions/000110.htm [57] The Role of Specific Components of a Plant-Based Diet in … https://pmc.ncbi.nlm.nih.gov/articles/PMC7551487/ [58] 6 common “heart-health” supplements ineffective at lowering … https://newsroom.heart.org/news/6-common-heart-health-supplements-ineffective-at-lowering-cholesterol-compared-to-statins [59] Nutrition interventions for adults with dyslipidemia – PubMed https://pubmed.ncbi.nlm.nih.gov/37271600/ [60] Effectiveness of altering serum cholesterol levels without drugs – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC1312230/ [61] The Impact of the Mediterranean Diet and Lifestyle Intervention on … https://www.mdpi.com/1422-0067/25/2/1338 [62] Portfolio Diet: Lower Your Cholesterol One Bite at a Time with Plant … https://www.orlandohealth.com/content-hub/portfolio-diet-lower-your-cholesterol-one-bite-at-a-time-with-plant-based-eating [63] 8 Natural Cholesterol Reducers – Healthline https://www.healthline.com/health/high-cholesterol/natural-cholesterol-reducers [64] Improving Your Cholesterol with Diet and Exercise | AAFP https://www.aafp.org/pubs/afp/issues/2010/0501/p1103.html [65] Mediterranean diet for heart health – Mayo Clinic https://www.mayoclinic.org/healthy-lifestyle/nutrition-and-healthy-eating/in-depth/mediterranean-diet/art-20047801 [66] Top 10 Plant-Based Foods to Lower Cholesterol https://www.purelyplanted.com/post/top-10-plant-based-foods-to-lower-cholesterol [67] Best supplements for lowering cholesterol – MedicalNewsToday https://www.medicalnewstoday.com/articles/cholesterol-lowering-supplements [68] Cooking to Lower Cholesterol | American Heart Association https://www.heart.org/en/health-topics/cholesterol/prevention-and-treatment-of-high-cholesterol-hyperlipidemia/cooking-to-lower-cholesterol [69] Can the Mediterranean Diet Lower Your Cholesterol? https://www.verywellhealth.com/mediterranean-diet-to-reduce-cholesterol-697647 [70] Plant-Based Diets and Your Cholesterol – WebMD https://www.webmd.com/cholesterol-management/features/plant-based-diets-and-cholesterol [71] Mediterranean Meal Plan to Lower Cholesterol – EatingWell https://www.eatingwell.com/article/7740264/mediterranean-meal-plan-to-lower-cholesterol/ [72] Lower cholesterol with a plant-based diet, study says – CNN https://edition.cnn.com/2023/05/24/health/vegetarian-vegan-diet-reduce-cholesterol-wellness/index.html [73] Lipid Management in Peripheral Artery Disease: A Focus on Recent … https://www.acc.org/Latest-in-Cardiology/Articles/2024/08/19/10/45/Lipid-Management-in-Peripheral-Artery-Disease [74] Association of Major Adverse Cardiac Events up to 5 Years in … https://www.ahajournals.org/doi/10.1161/JAHA.118.010541 [75] More- Versus Less-Intensive Lipid-Lowering Therapy – AHA Journals https://www.ahajournals.org/doi/10.1161/CIRCOUTCOMES.118.005460 [76] Association of Treatment Intensity and Adherence to Lipid-Lowering … https://pmc.ncbi.nlm.nih.gov/articles/PMC8107155/ [77] Lipid-lowering therapies for cardiovascular disease prevention and … https://pmc.ncbi.nlm.nih.gov/articles/PMC10575662/ [78] Defining the need for cardiovascular event definitions https://academic.oup.com/ehjqcco/article/10/2/105/7596555 [79] Risk of major adverse cardiovascular events associated … – BMJ Open https://bmjopen.bmj.com/content/13/11/e064541 [80] Heart Failure and Major Adverse Cardiovascular Events in Atrial … https://www.mdpi.com/2227-9059/11/7/1825 [81] Occurence of First and Recurrent Major Adverse Cardiovascular … https://jamanetwork.com/journals/jamacardiology/fullarticle/2754760 [82] Comparison of Major Adverse Cardiac Events Between … https://jamanetwork.com/journals/jamacardiology/fullarticle/2738103 [83] Effectiveness of lipid-lowering therapy on mortality and major … https://pmc.ncbi.nlm.nih.gov/articles/PMC10660972/ [84] Navigating the “MACE” in Cardiovascular Outcomes Trials and … https://dom-pubs.onlinelibrary.wiley.com/doi/full/10.1111/dom.13740 [85] Reductions in Atherogenic Lipids and Major Cardiovascular Events https://www.ahajournals.org/doi/10.1161/circulationaha.116.024604 [86] Prediction of Major Adverse Cardiovascular Events in Patients With … https://www.ahajournals.org/doi/10.1161/CIRCGEN.121.003546
Everyday (including today) I must build a case for the timely use of a statin agent, overcoming the vilification these medicines face in popular culture. In reality, compelling evidence, based on well conducted studies, have shown the profound beneficial effects of these medications. Indeed, statins have revolutionized cardiovascular disease prevention and treatment since their introduction. This post will delve into the wealth of data from statin trials, exploring their efficacy, pleiotropic effects, and key concepts like number needed to treat (NNT). We’ll also examine specific trials and rank statins by their power in reducing cardiovascular events.
Statin Efficacy: The Big Picture
Numerous large-scale trials have consistently demonstrated the efficacy of statins in reducing cardiovascular events. The evidence is particularly strong for secondary prevention (in patients with established cardiovascular disease) but is also significant for primary prevention in high-risk individuals[1][2].
Key findings from major statin trials include:
Reduction in major adverse cardiovascular events (MACE)
The Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA) was a landmark study that demonstrated the benefits of statins in primary prevention[8][9]. This trial randomized hypertensive patients with relatively low cholesterol levels to atorvastatin 10 mg or placebo.
Key ASCOT-LLA findings:
36% reduction in the primary endpoint (non-fatal myocardial infarction and fatal coronary heart disease)
Early separation of event curves, suggesting rapid onset of benefit (in as few as 2 months)
Persistent benefit even after trial termination, indicating a potential “legacy effect”
The rapid separation of event curves in ASCOT-LLA is particularly intriguing. It suggests that statins may provide cardiovascular protection even before their full lipid-lowering effects are realized, supporting the concept of pleiotropic effects[8].
Pleiotropic Effects: Beyond Lipid-Lowering
Statins may exert cardiovascular protective effects independent of LDL-C lowering, known as “pleiotropic” effects[7]. These include:
Improved endothelial function (cells that line the arteries)
Antioxidant properties
Anti-inflammatory effects
Plaque stabilization
While some studies support these pleiotropic effects, the clinical relevance remains debated. Some trials have shown greater benefits with high-dose statins compared to lower doses plus ezetimibe, despite similar LDL-C lowering[7]. However, other studies have not found such differences, leaving the question of pleiotropy open to further research.
Number Needed to Treat (NNT)
The NNT is a valuable concept in understanding the real-world impact of statin therapy. It represents the number of patients who need to be treated to prevent one adverse event.
In the UK arm of ASCOT-LLA, the NNT to prevent one death from atorvastatin treatment for 3.3 years was 286[1]. This number improved over time, highlighting the cumulative benefit of statin therapy.
A meta-analysis of primary prevention trials found that treating 100 adults (aged 50-75 years) with a statin for 2.5 years prevented 1 MACE in 1 adult[2]. This translates to an NNT of 100 over 2.5 years for primary prevention.
Major Statin Trials: A Summary
4S (Scandinavian Simvastatin Survival Study): Demonstrated mortality (reducing death) benefit in secondary prevention with simvastatin[8].
WOSCOPS (West of Scotland Coronary Prevention Study): Showed pravastatin’s efficacy in primary prevention[2].
CARE (Cholesterol and Recurrent Events): Established pravastatin’s benefit in patients with average cholesterol levels post-MI[8].
LIPID (Long-Term Intervention with Pravastatin in Ischaemic Disease): Confirmed pravastatin’s long-term benefits in a broad range of patients[8].
JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin): Demonstrated rosuvastatin’s efficacy in primary prevention for patients with elevated C-reactive protein[2].
PROVE-IT (Pravastatin or Atorvastatin Evaluation and Infection Therapy): Compared aggressive (atorvastatin 80 mg) vs. moderate (pravastatin 40 mg) statin therapy[5].
ASCOT-LLA: Showed atorvastatin’s benefit in primary prevention for hypertensive patients[8][9].
Ranking Statins by Event Reduction
While all statins have shown efficacy, some appear more potent in reducing cardiovascular events:
Atorvastatin (high-intensity)
Rosuvastatin (high-intensity)
Simvastatin (moderate to high-intensity)
Pravastatin (low to moderate-intensity)
Fluvastatin (low-intensity)
This ranking is based on their lipid-lowering potency and evidence from comparative trials[3][5]. However, it’s important to note that individual patient factors should guide statin selection. Our preference is for rosuvastatin, due to less musculoskeletal effects and profound reduction of LDL, even at lower doses.
CVA vs. MACE Data
While statins consistently reduce MACE, or major adverse cardiac events, (which typically includes cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke), their effect on cerebrovascular accidents (CVA) alone is less pronounced.
Most trials show a significant reduction in overall MACE, but the effect on stroke (CVA) is often smaller or non-significant when analyzed separately. For instance, in ASCOT-LLA, while there was a significant reduction in MACE, the reduction in fatal and non-fatal stroke was not statistically significant[8][9].
In conclusion, the wealth of data from statin trials provides strong evidence for their efficacy in reducing cardiovascular events, particularly in high-risk individuals and for secondary prevention. While questions remain about the extent of their pleiotropic effects and the optimal approach to primary prevention, statins remain a cornerstone of cardiovascular risk reduction. As with all medical interventions, the decision to initiate statin therapy should be based on individual patient factors and shared decision-making.
Sources [1] 11-year mortality follow-up of the lipid-lowering arm in the UK … https://academic.oup.com/eurheartj/article/32/20/2525/487760?login=false [2] Evaluation of Time to Benefit of Statins for the Primary Prevention of … https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2773065 [3] Comparative Effectiveness of Statin Therapy in Reducing … https://www.heraldopenaccess.us/openaccess/comparative-effectiveness-of-statin-therapy-in-reducing-cardiovascular-events [4] Ongoing Clinical Trials of the Pleiotropic Effects of Statins – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC1993933/ [5] Improving outcomes through statin therapy – a review of ongoing trials https://academic.oup.com/eurheartjsupp/article/6/suppl_A/A28/386696 [6] Time to Benefit of Statins for Primary Prevention of Cardiovascular … https://www.acc.org/latest-in-cardiology/journal-scans/2020/11/24/18/25/evaluation-of-time-to-benefit-of-statins [7] Pleiotropic Effects of Statins on the Cardiovascular System – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC5467317/ [8] Long-term results from statin trials: answers but more unresolved … https://academic.oup.com/eurheartj/article/32/20/2479/487295 [9] Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2010/02/22/19/05/ASCOT–Lipid-Arm
A common conversation I have with my patients involves the implications of the eGFR, or estimated glomerular filtration rate. This value is on every chemistry panel we order and is often found to be diminished, frequently unexpectedly, on blood work. This can be anxiety provoking, and is certainly confusing, inasmuch as this dysfunction is usually asymptomatic and has significant health implications.
Chronic Kidney Disease (CKD) is a progressive condition affecting millions worldwide. This guide aims to demystify CKD, its stages, and evidence-based strategies for management.
The Stages of CKD and the Importance of eGFR
Chronic Kidney Disease is classified into five stages based on the estimated Glomerular Filtration Rate (eGFR), a measure of how well the kidneys filter waste from the blood. The eGFR is calculated using serum creatinine levels, age, sex, and race.
CKD stages:
Stage 1: Kidney damage with normal or increased GFR (>90 mL/min/1.73 m²)
Stage 2: Mild reduction in GFR (60-89 mL/min/1.73 m²)
Stage 3a: Moderate reduction in GFR (45-59 mL/min/1.73 m²)
Stage 3b: Moderate reduction in GFR (30-44 mL/min/1.73 m²)
Stage 4: Severe reduction in GFR (15-29 mL/min/1.73 m²)
Stage 5: Kidney failure (GFR <15 mL/min/1.73 m² or dialysis)
Understanding these stages is crucial for diagnosis and treatment planning. As the disease progresses, the risk of complications increases, making early detection and intervention vital.
Blood Pressure Control: Maintaining optimal blood pressure is crucial in slowing CKD progression.
Glycemic Control: For diabetic patients, tight glycemic (blood sugar) control can significantly reduce the risk of kidney damage.
Dietary Changes: A low-sodium, low-protein diet can help reduce the workload on the kidneys.
Exercise: Regular physical activity can improve overall health and help manage comorbidities like hypertension and diabetes.
Pharmacological Interventions: medicines to treat CKD
Several medications have shown promise in preserving kidney function:
ACE Inhibitors and ARBs: These medications help control blood pressure and reduce proteinuria, slowing CKD progression.
SGLT2 Inhibitors: Originally developed for diabetes, these drugs have shown remarkable renoprotective effects in both diabetic and non-diabetic CKD patients.
Mineralocorticoid Receptor Antagonists (MRAs): Drugs like spironolactone and eplerenone can help manage resistant hypertension and reduce proteinuria.
Finerenone: A non-steroidal MRA that has shown promising results in reducing both renal and cardiovascular outcomes in patients with diabetic kidney disease.
Dietary Considerations for Advanced CKD
As kidney function declines, dietary restrictions become more crucial:
Protein Intake: Moderate protein consumption is recommended. Too much protein can overwork the kidneys, while too little may lead to malnutrition.
Sodium Restriction: Limiting sodium (salt) helps control blood pressure and reduces fluid buildup.
Potassium Management: Foods high in potassium (e.g., oranges, potatoes, tomatoes) should be limited as excess potassium can cause heart problems.
Phosphorus Control: Reduce intake of foods high in phosphorus (meat, dairy, beans, nuts, whole-grain bread) to prevent bone weakening and blood vessel damage.
Fluid Restriction: In advanced stages, limiting fluid intake becomes necessary to prevent fluid buildup.
Carbohydrates: white bread, unsalted crackers, pasta
Things to Avoid
Artificial Sweeteners: While the relationship between artificial sweeteners and CKD risk is not definitively established, some studies suggest a potential link. Caution is advised.
Proton Pump Inhibitors (PPIs): Long-term use of PPIs has been associated with an increased risk of CKD. If prescribed, discuss the risks and benefits with your healthcare provider.
Herbal Supplements: Many herbal supplements can be harmful to kidney function. Avoid supplements like astragalus, horsetail, licorice root, and others without consulting a healthcare professional.
High-Potassium Foods: In advanced stages, limit intake of high-potassium foods like bananas, oranges, and potatoes.
Phosphate-Rich Foods: Reduce consumption of dairy products, nuts, and cola drinks.
Excessive Protein: Especially from red meat sources.
Alcohol: Limit or avoid alcohol consumption as it can interfere with kidney function and medications.
Raw or Unpasteurized Foods: These may increase the risk of foodborne illnesses in immunocompromised individuals.
Nephrotoxic Medications: NSAIDs, certain antibiotics, and contrast dyes should be used cautiously or avoided in CKD patients.
Smoking: Tobacco use can accelerate kidney damage and should be discontinued.
When to Consult a Nephrologist
Referral to a nephrologist (kidney specialist) is typically recommended in the following situations:
eGFR <30 mL/min/1.73 m² (Stage 4 or 5 CKD)
Rapid decline in kidney function
Persistent proteinuria (protein in urine)
Difficult-to-control hypertension
Recurrent or extensive nephrolithiasis (kidney stones)
Hereditary kidney disease
Early referral has been associated with better outcomes, including reduced mortality rates in the first 90 days of dialysis.
Workup of Kidney Dysfunction
A comprehensive evaluation of kidney function typically includes:
Laboratory Tests:
Serum creatinine and eGFR calculation
Urine albumin-to-creatinine ratio (to measure protein loss in urine)
Complete blood count
Serum electrolytes
Lipid profile
Hemoglobin A1C (for diabetic patients)
Imaging studies
Renal ultrasonography to evaluate kidney size and structure
CT or MRI scans in specific cases
Additional Tests (as needed):
24-hour urine collection for protein and creatinine clearance
Kidney biopsy in cases where the etiology is unclear
Conclusion
Chronic Kidney Disease is a complex condition that requires a multifaceted approach to management. By understanding the stages of CKD, the importance of eGFR, and implementing evidence-based strategies, we can significantly improve outcomes for our patients. Early detection, lifestyle modifications, appropriate medication use, and timely referral to nephrology can all contribute to preserving kidney function and enhancing quality of life for those living with CKD.
Remember, each patient is unique, and treatment plans should be tailored to individual needs and circumstances. By staying informed about the latest advancements in CKD management, we can provide the best possible care for our patients.
Sources
National Kidney Foundation. (2023). Kidney Failure Risk Factor: Estimated Glomerular Filtration Rate (eGFR). Retrieved from https://www.kidney.org/kidney-failure-risk-factor-estimated-glomerular-filtration-rate-egfr
Webster, A. C., Nagler, E. V., Morton, R. L., & Masson, P. (2017). Chronic Kidney Disease. The Lancet, 389(10075), 1238-1252.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. (2013). KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements, 3(1), 1-150.
Brenner, B. M., Cooper, M. E., de Zeeuw, D., et al. (2001). Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy. New England Journal of Medicine, 345(12), 861-869.
Perkovic, V., Jardine, M. J., Neal, B., et al. (2019). Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. New England Journal of Medicine, 380(24), 2295-2306.
Bakris, G. L., Agarwal, R., Anker, S. D., et al. (2020). Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. New England Journal of Medicine, 383(23), 2219-2229.
National Institute of Diabetes and Digestive and Kidney Diseases. (2022). Eating Right for Chronic Kidney Disease. Retrieved from https://www.niddk.nih.gov/health-information/kidney-disease/chronic-kidney-disease-ckd/eating-nutrition
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2016). Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD. Journal of the American Society of Nephrology, 27(10), 3153-3163.
Kidney Research UK. (2023). Healthy eating for kidney patients. Retrieved from https://www.kidneyresearchuk.org/kidney-health-information/living-with-kidney-disease/how-can-i-help-myself/healthy-eating-for-kidney-patients/
Smart, N. A., Dieberg, G., Ladhani, M., & Titus, T. (2014). Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database of Systematic Reviews, (6).
Levey, A. S., & Coresh, J. (2012). Chronic kidney disease. The Lancet, 379(9811), 165-180.
Centers for Disease Control and Prevention. (2023). Diabetes and Kidney Disease: What to Eat. Retrieved from https://www.cdc.gov/diabetes/healthy-eating/diabetes-and-kidney-disease-food.html
National Kidney Foundation. (2023). Herbal Supplements and Kidney Disease. Retrieved from https://www.kidney.org/kidney-topics/herbal-supplements-and-kidney-disease
